BOULDER, Colo., June 7 /PRNewswire-FirstCall/ -- Tapestry Pharmaceuticals, Inc. (NASDAQ:TPPH) announced today that management will provide a company update at the 6th Annual Needham & Company Biotechnology and Medical Technology Conference on Wednesday, June 13th, 2007 at 2:00 p.m. EDT. The conference is being held at The New York Palace Hotel in New York City. A live audio webcast of the call will be available on the "Investors" section of the Company's website, http://www.tapestrypharma.com/. The audio webcast will not be archived.
About Tapestry Pharmaceuticals, Inc.
Tapestry Pharmaceuticals, Inc. is a company focused on the development of proprietary therapies for the treatment of cancer. For more information about Tapestry and its technologies, visit Tapestry's web site at http://www.tapestrypharma.com/.
Contact: Tapestry Pharmaceuticals, Inc. Gordon Link
Senior Vice President,
Chief Financial Officer
303-516-8500
Elma Hawkins, Ph.D. Communications and Corporate Development
212-400-3019
Investor: Lilian Stern
Stern Investor Relations, Inc. 212-362-1200
Media: Dana Conti
Schwartz Communications, Inc. 781-684-0770
DATASOURCE: Tapestry Pharmaceuticals, Inc.
CONTACT: Gordon Link, Senior Vice President, Chief Financial Officer, +1-303-516-8500, , or Elma Hawkins, Ph.D., Communications and Corporate Development, +1-212-400-3019, , both of Tapestry Pharmaceuticals, Inc.; or Investor: Lilian Stern, of Stern Investor Relations, Inc., +1-212-362-1200, ; or Media: Dana Conti, of Schwartz Communications, Inc., +1-781-684-0770, , both for Tapestry Pharmaceuticals, Inc.
Web site: http://www.tapestrypharma.com/
|